110 related articles for article (PubMed ID: 14764044)
1. Comparison of hepatocyte growth factor levels of epithelial ovarian cancer cyst fluids with benign ovarian cysts.
Baykal C; Demirtaş E; Al A; Ayhan A; Yüce K; Tulunay G; Köse MF; Ayhan A
Int J Gynecol Cancer; 2004; 14(1):152-6. PubMed ID: 14764044
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HGF (hepatocyte growth factor) levels of epithelial ovarian cancer cyst fluids with benign ovarian cysts.
Baykal C; Demirtas E; Al A; Ayhan A; Yuce K; Tulunay G; Kose MF; Ayhan A
Int J Gynecol Cancer; 2003; 13(6):771-5. PubMed ID: 14675313
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells.
Sowter HM; Corps AN; Smith SK
Int J Cancer; 1999 Nov; 83(4):476-80. PubMed ID: 10508482
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
7. FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.
Rzepka-Górska I; Chudecka-Głaz A; Kosmowska B
Endocr Relat Cancer; 2004 Jun; 11(2):315-21. PubMed ID: 15163306
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer.
Karasik A; Menczer J; Pariente C; Kanety H
J Clin Endocrinol Metab; 1994 Feb; 78(2):271-6. PubMed ID: 7508947
[TBL] [Abstract][Full Text] [Related]
9. Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer.
Parrott JA; Skinner MK
Biol Reprod; 2000 Mar; 62(3):491-500. PubMed ID: 10684788
[TBL] [Abstract][Full Text] [Related]
10. [Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance].
Zhang RT; Shi HR; Huang HL; Chen ZM; Liu HN; Yuan ZF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1551-5. PubMed ID: 21945764
[TBL] [Abstract][Full Text] [Related]
11. Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer.
Bischof A; Briese V; Richter DU; Bergemann C; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1639-44. PubMed ID: 16033074
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
Hazelton D; Nicosia RF; Nicosia SV
Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
[TBL] [Abstract][Full Text] [Related]
14. Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features.
Wei W; Kong B; Qu X
J Obstet Gynaecol Res; 2012 Jan; 38(1):57-64. PubMed ID: 22136730
[TBL] [Abstract][Full Text] [Related]
15. Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis.
Aune G; Lian AM; Tingulstad S; Torp SH; Forsmo S; Reseland JE; Stunes AK; Syversen U
Gynecol Oncol; 2011 May; 121(2):402-6. PubMed ID: 21284996
[TBL] [Abstract][Full Text] [Related]
16. Origin of ovarian cancer from benign cysts.
Dal Maso L; Canzonieri V; Talamini R; Franceschi S; La Vecchia C
Eur J Cancer Prev; 2001 Apr; 10(2):197-9. PubMed ID: 11330466
[TBL] [Abstract][Full Text] [Related]
17. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
Candido Dos Reis F; Moreira de Andrade J; Bighetti S
Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
Lee S; Garner EI; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
[TBL] [Abstract][Full Text] [Related]
19. Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma.
Fujimura M; Hidaka T; Kataoka K; Yamakawa Y; Akada S; Teranishi A; Saito S
Am J Surg Pathol; 2001 May; 25(5):667-72. PubMed ID: 11342781
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the effusions of ovarian epithelial neoplasms.
Kutteh WH; Kutteh CC
Am J Obstet Gynecol; 1992 Dec; 167(6):1864-9. PubMed ID: 1471711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
